Our results further verify that overexpression of PLPP4 is observed in the glioma and PAAD tissues and cells and positively correlates with advanced clinicopathological features and poor prognosis in glioma and PAAD patients. This evidence concerns the gene PLPP4 and central nervous system cancer.